Physician profile
Charles Wesley Grayson
NPI 1629076252
$2,473.90
in general payments reported to CMS, 2019-2025
23 companies · $408 in 2025
The $408 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $102 · 2021: $296 · 2022: $300 · 2023: $226 · 2024: $1,031 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,093 · Debt Forgiveness: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,093.30 |
| Debt Forgiveness | $571.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Photonicare INC | $571.43 | 2024 | Otosight Middle Ear Scope |
| Genzyme Corporation | $430.73 | 2020-2025 | |
| Glaxosmithkline, LLC. | $295.81 | 2021-2025 | Nucala |
| Aerin Medical INC. | $244.15 | 2019-2025 | |
| Genmab U.S., INC. | $127.30 | 2024 | |
| Intersect Ent, INC. | $112.88 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $105.20 | 2019-2024 | Dupixent, Libtayo |
| Optinose US, INC. | $88.56 | 2022-2024 | |
| Stryker Corporation | $87.80 | 2020-2025 | Audion Et Dilation System |
| Smith+Nephew, INC. | $73.75 | 2019-2023 | Grafix Pl |
| Merck Sharp & Dohme LLC | $64.83 | 2021-2025 | Keytruda |
| Inspire Medical Systems, INC. | $59.90 | 2024 | Inspire |
| Hikma Pharmaceuticals USA | $39.61 | 2022-2023 | Ryaltris |
| Acclarent, INC | $29.98 | 2019-2020 | |
| Boston Scientific Corporation | $24.97 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $23.66 | 2025 | Tezspire |
| Integra Lifesciences Corporation | $20.54 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Paratek Pharmaceuticals, INC. | $15.36 | 2025 | Xhance |
| Cochlear Americas | $13.88 | 2023 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Shire North American Group INC | $13.81 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.12 | 2021 | |
| Ethicon US, LLC | $11.59 | 2021 | |
| Phathom Pharmaceuticals, INC. | $6.04 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Grayson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.